Westpac Banking Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
13,703
-519
-4% -$526K 0.88% 17
2025
Q4
$15.3M Buy
14,222
+4,030
+40% +$3.85M 0.97% 14
2025
Q3
$7.78M Sell
10,192
-4,384
-30% -$3.26M 0.48% 47
2025
Q2
$11.4M Sell
14,576
-3,260
-18% -$2.53M 0.76% 20
2025
Q1
$14.7M Sell
17,836
-8,210
-32% -$6.83M 1.08% 13
2024
Q4
$20.1M Sell
26,046
-2,828
-10% -$2.34M 1.33% 8
2024
Q3
$25.6M Buy
28,874
+5,820
+25% +$5.23M 1.71% 7
2024
Q2
$20.9M Buy
23,054
+1,370
+6% +$1.1M 1.66% 7
2024
Q1
$16.9M Sell
21,684
-1,447
-6% -$1.03M 1.29% 10
2023
Q4
$13.5M Sell
23,131
-17,565
-43% -$10.3M 1.11% 12
2023
Q3
$21.9M Buy
40,696
+11,450
+39% +$5.9M 1.64% 10
2023
Q2
$13.7M Sell
29,246
-147,552
-83% -$61.9M 0.97% 16
2023
Q1
$60.7M Buy
176,798
+22,238
+14% +$7.5M 0.82% 12
2022
Q4
$56.5M Sell
154,560
-3,562
-2% -$1.26M 0.84% 10
2022
Q3
$51.1M Buy
158,122
+7,688
+5% +$2.44M 0.78% 13
2022
Q2
$48.8M Sell
150,434
-7,992
-5% -$2.4M 0.64% 18
2022
Q1
$45.4M Sell
158,426
-44,275
-22% -$11.4M 0.52% 24
2021
Q4
$56M Sell
202,701
-40,383
-17% -$10.2M 0.58% 24
2021
Q3
$56.2M Sell
243,084
-63,905
-21% -$15.8M 0.6% 22
2021
Q2
$70.5M Sell
306,989
-44,837
-13% -$9.01M 0.71% 15
2021
Q1
$65.7M Buy
351,826
+136,289
+63% +$26.7M 0.73% 15
2020
Q4
$36.4M Buy
215,537
+78,671
+57% +$11.7M 0.41% 42
2020
Q3
$20.3M Buy
136,866
+5,701
+4% +$882K 0.27% 88
2020
Q2
$21.5M Sell
131,165
-13,950
-10% -$2.14M 0.32% 74
2020
Q1
$20.1M Buy
145,115
+10,272
+8% +$1.41M 0.35% 72
2019
Q4
$17.7M Sell
134,843
-622
-0.5% -$72.1K 0.23% 116
2019
Q3
$15.1M Sell
135,465
-10,604
-7% -$1.18M 0.21% 130
2019
Q2
$16.2M Buy
146,069
+7,663
+6% +$902K 0.25% 110
2019
Q1
$18M Sell
138,406
-19,456
-12% -$2.37M 0.3% 88
2018
Q4
$18.3M Buy
157,862
+14,949
+10% +$1.67M 0.31% 84
2018
Q3
$15.3M Buy
142,913
+24,644
+21% +$2.46M 0.26% 110
2018
Q2
$10.1M Hold
118,269
0.19% 147
2018
Q1
$9.15M Buy
118,269
+24,400
+26% +$1.96M 0.18% 164
2017
Q4
$7.93M Buy
93,869
+9,250
+11% +$787K 0.18% 160
2017
Q3
$7.24M Buy
84,619
+8,595
+11% +$705K 0.16% 199
2017
Q2
$6.26M Sell
76,024
-22,230
-23% -$1.81M 0.14% 211
2017
Q1
$8.26M Sell
98,254
-48
-0% -$3.85K 0.07% 289
2016
Q4
$7.73M Buy
98,302
+2,599
+3% +$194K 0.07% 282
2016
Q3
$7.68M Buy
95,703
+2,060
+2% +$165K 0.08% 253
2016
Q2
$7.19M Sell
93,643
-5,905
-6% -$445K 0.08% 282
2016
Q1
$7.17M Buy
99,548
+4,711
+5% +$356K 0.08% 263
2015
Q4
$7.99M Buy
94,837
+40,213
+74% +$3.34M 0.09% 218
2015
Q3
$4.57M Buy
54,624
+34,822
+176% +$2.94M 0.05% 325
2015
Q2
$1.65M Sell
19,802
-243,364
-92% -$18.5M 0.02% 442
2015
Q1
$22.4M Sell
263,166
-142,828
-35% -$10.2M 0.19% 120
2014
Q4
$28M Sell
405,994
-47,126
-10% -$3.18M 0.27% 81
2014
Q3
$29.4M Sell
453,120
-140,102
-24% -$8.87M 0.29% 68
2014
Q2
$36.9M Sell
593,222
-50,870
-8% -$3.04M 0.36% 53
2014
Q1
$37.9M Sell
644,092
-139,831
-18% -$7.8M 0.4% 54
2013
Q4
$40M Buy
783,923
+9,736
+1% +$488K 0.46% 40
2013
Q3
$39M Buy
774,187
+140,946
+22% +$7.38M 0.49% 43
2013
Q2
$33.5M Buy
+633,241
New +$34.5M 0.51% 47

Other funds holding LLY

Westpac Banking Corp's LLY Position: Q1 2026 in Review

Westpac Banking Corp reduced its Eli Lilly (LLY) stake by 3.6% in Q1 2026, selling an estimated $526K and leaving 13,703 shares worth $12.6M. The position accounts for 0.88% of the portfolio, ranked #17.

Westpac Banking Corp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $70.5M in Q2 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Westpac Banking Corp held 13,703 shares of Eli Lilly worth $12.6M as of Q1 2026.
  • Westpac Banking Corp sold 519 Eli Lilly shares in Q1 2026, an estimated $526K.
  • Eli Lilly made up 0.88% of Westpac Banking Corp's portfolio in Q1 2026, its #17 holding.
  • Westpac Banking Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Eli Lilly position peaked at $70.5M in Q2 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.